Tech Company Financing Transactions

Ventus Therapeutics Funding Round

Ventus Therapeutics, based in Waltham, scored $60 million in funding from Versant Ventures and GV.

Transaction Overview

Announced On
5/7/2020
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series A
Investors

Versant Ventures (Lead Investor) (Jerel Davis)

GV

Proceeds Purpose
Proceeds will be used to advance three pipeline programs and to expand the company's structural immunology platform to pursue previously intractable drug targets.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Beaver St. 202
Waltham, MA 02453
USA
Email Address
Overview
At Ventus, we are focused on discovering and developing novel therapeutics that target the innate immune system with the goal of addressing autoimmune diseases, inflammatory diseases, and cancer. Guided by a patient-centric ethos, our aim is to rapidly advance multiple drug candidates. Our emerging pipeline focuses on the inflammasome and nucleic acid sensing pathways.
Profile
Ventus Therapeutics LinkedIn Company Profile
Social Media
Ventus Therapeutics Company Twitter Account
Company News
Ventus Therapeutics News
Facebook
Ventus Therapeutics on Facebook
YouTube
Ventus Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Hao Wu
  Hao Wu LinkedIn Profile  Hao Wu Twitter Account  Hao Wu News  Hao Wu on Facebook
Chief Executive Officer
Marcelo Bigal
  Marcelo Bigal LinkedIn Profile  Marcelo Bigal Twitter Account  Marcelo Bigal News  Marcelo Bigal on Facebook
Chief Financial Officer
Zack McNealy
  Zack McNealy LinkedIn Profile  Zack McNealy Twitter Account  Zack McNealy News  Zack McNealy on Facebook
Founder
Richard Flavell
  Richard Flavell LinkedIn Profile  Richard Flavell Twitter Account  Richard Flavell News  Richard Flavell on Facebook
Founder
Judy Lieberman
  Judy Lieberman LinkedIn Profile  Judy Lieberman Twitter Account  Judy Lieberman News  Judy Lieberman on Facebook
Founder
Thomas Tuschl
  Thomas Tuschl LinkedIn Profile  Thomas Tuschl Twitter Account  Thomas Tuschl News  Thomas Tuschl on Facebook
Vice President
Michael Turner
  Michael Turner LinkedIn Profile  Michael Turner Twitter Account  Michael Turner News  Michael Turner on Facebook
VP - Bus. Development
Daniel Koerwer
  Daniel Koerwer LinkedIn Profile  Daniel Koerwer Twitter Account  Daniel Koerwer News  Daniel Koerwer on Facebook
VP - R & D
Michael Crackower
  Michael Crackower LinkedIn Profile  Michael Crackower Twitter Account  Michael Crackower News  Michael Crackower on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/6/2020: GigaSpaces Technologies venture capital transaction
Next: 5/7/2020: LetsGetChecked venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary